Resonant Therapeutics, Inc. — Form D
Resonant Therapeutics, Inc. of Houston, TX, a company, filed a Form D exempt-offering notice with the SEC on 2017-08-09. The offering totals $2.6M, of which $1.4M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2017-08-09
- Form: D
- Accession: 0001656695-17-000001
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $2.6M
- Amount sold: $1.4M
- Remaining: $1.3M
- Minimum investment: $25K
- Investors: 3
- Date of first sale: 2017-08-03
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-292422
Issuer
- Name: Resonant Therapeutics, Inc.
- CIK: 0001656695
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2014
- Address: 2450 Holcombe Blvd., Houston, TX, 77021
- Phone: 925.389.8539
Officers, directors & promoters (4)
| Name | Role | Location |
|---|
| Dan K Watkins | Executive Officer | Houston, TX |
| John K Westwick | Director | Houston, TX |
| John K Westwick | Executive Officer | Houston, TX |
| Dan K Watkins | Director | Houston, TX |
Other filings by this issuer (2)
More